{"content":"<li class=\"n-box-item date-title\" data-end=\"1385182799\" data-start=\"1385096400\" data-txt=\"Friday, December 20, 2019\">Friday, November 22, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1429701\" data-ts=\"1385162157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429701-supervalu-closes-higher-after-disclosing-change-of-control-packages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu closes higher after disclosing change-of-control packages</a></h4><ul><li>Supervalu (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='green'>+7.2%</font>) discloses its CEO, CFO, and several other execs will receive major severance benefits in the event they lose their jobs following a change of control. The benefits include sizable lump sump cash payments, as well as unpaid bonus money. (<a href=\"http://biz.yahoo.com/e/131122/svu8-k.html\" target=\"_blank\">8-K</a>)</li><li>The disclosure has raised investor hopes the debt-laden supermarket chain will find a suitor.</li></ul><div class=\"tiny-share-widget\" data-id=\"1429701\" data-linked=\"Supervalu closes higher after disclosing change-of-control packages\" data-tweet=\"$SVU - Supervalu closes higher after disclosing change-of-control packages https://seekingalpha.com/news/1429701-supervalu-closes-higher-after-disclosing-change-of-control-packages?source=tweet\" data-url=\"https://seekingalpha.com/news/1429701-supervalu-closes-higher-after-disclosing-change-of-control-packages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429641\" data-ts=\"1385159798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429641-after-hour-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After hour Gainers / Losers</a></h4><ul><li><b>Top Gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AMBI' title='Ambit Biosciences Corp'>AMBI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/MODN' title='Model N'>MODN</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='green'>+6%</font>.</li><li><b>Top Losers</b><b><b>, as of 5:15 p.m.</b>:</b> <a href='https://seekingalpha.com/symbol/DNDN' title='Dendreon Corporation'>DNDN</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/NNBR' title='NN, Inc.'>NNBR</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/DLLR' title='DFC Global Corp.'>DLLR</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy'>PBF</a> <font color='red'>-2%</font>. <a href='https://seekingalpha.com/symbol/VLY' title='Valley National Bancorp'>VLY</a> <font color='red'>-2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1429641\" data-linked=\"After hour Gainers / Losers\" data-tweet=\"$DVA $CAMT $AMBI - After hour Gainers / Losers https://seekingalpha.com/news/1429641-after-hour-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1429641-after-hour-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429611\" data-ts=\"1385159261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWGP\" target=\"_blank\">TWGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429611-tower-group-international-eps-of-5_10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tower Group International EPS of -$5.10</a></h4><ul>\n<li>Tower Group International (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TWGP\" title=\"Tower Group, Inc.\">TWGP</a>): FQ2 EPS of -$5.10.</li>\n<li>Revenue of $460.51M. Shares  <font color=\"red\">-2.81%</font> AH. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429611\" data-linked=\"Tower Group International EPS of -$5.10\" data-tweet=\"$TWGP - Tower Group International EPS of -$5.10 https://seekingalpha.com/news/1429611-tower-group-international-eps-of-5_10?source=tweet\" data-url=\"https://seekingalpha.com/news/1429611-tower-group-international-eps-of-5_10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429501\" data-ts=\"1385156860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429501-unipixel-discloses-sec-investigation-shares-minus-16_9-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniPixel discloses SEC investigation, shares -16.9% AH</a></h4><ul>\n<li>UniPixel (NASDAQ:<a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a>) discloses the SEC's Fort Worth, TX office has \"issued subpoenas concerning the Company\u2019s agreements related to its InTouch Sensors.\" The company says it won't comment further on the matter until it's closed or further SEC action is taken. (<a href=\"http://www.sec.gov/Archives/edgar/data/1171012/000118518513002575/unipixel8k112213.htm\" target=\"_blank\">8-K</a>)</li>\n<li>Various SA contributors <a href=\"https://seekingalpha.com/currents/post/1303392\" target=\"_blank\">have criticized</a> what they perceived to be a lack of details about UniPixel touch sensor agreements and production timetables. Shares crashed <a href=\"https://seekingalpha.com/currents/post/1400722\" target=\"_blank\">earlier this month</a> following a Q3 CC (<a href=\"https://seekingalpha.com/article/1820972-unipixels-ceo-discusses-q3-2013-results-earnings-call-transcript\" target=\"_blank\">transcript</a>) during which analysts pressed UniPixel about its InTouch deals and other matters.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429501\" data-linked=\"UniPixel discloses SEC investigation, shares -16.9% AH\" data-tweet=\"$UNXL - UniPixel discloses SEC investigation, shares -16.9% AH https://seekingalpha.com/news/1429501-unipixel-discloses-sec-investigation-shares-minus-16_9-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1429501-unipixel-discloses-sec-investigation-shares-minus-16_9-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429461\" data-ts=\"1385156029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUS\" target=\"_blank\">NUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429461-nu-skin-hits-fresh-52-week-high-as-deutsche-remains-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nu Skin hits fresh 52-week high as Deutsche remains bullish</a></h4><ul>\n<li>Nu Skin (NYSE:<a href=\"https://seekingalpha.com/symbol/NUS\" title=\"Nu Skin Enterprises Inc.\">NUS</a>) rises by more than <font color=\"green\">5%</font> to close at a new 52-week high. </li>\n<li>The shares are up <font color=\"green\">9.6%</font> over two days.<br>\n</li>\n<li>Deutsche's Greg Poole is out <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4103063/update-deutsche-bank-reiterates-on-nu-skin-enterprises-o\" target=\"_blank\">reiterating</a> a Buy rating and raising his price target to $130 from $127 citing a depressed multiple, impressive sales and EPS, and \"highly achievable\" 2014 guidance.</li>\n<li>As for Friday's gains, it probably didn't hurt that Bill Ackman's latest salvo in the Herbalife war didn't contain any earth-shattering indictments of the direct selling industry writ large.</li>\n<li>See also: NUS <a href=\"https://seekingalpha.com/currents/post/1425111\" target=\"_blank\">announces</a> 2014 outlook</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429461\" data-linked=\"Nu Skin hits fresh 52-week high as Deutsche remains bullish\" data-tweet=\"$NUS - Nu Skin hits fresh 52-week high as Deutsche remains bullish https://seekingalpha.com/news/1429461-nu-skin-hits-fresh-52-week-high-as-deutsche-remains-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/1429461-nu-skin-hits-fresh-52-week-high-as-deutsche-remains-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429451\" data-ts=\"1385155802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429451-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/fxi\" title=\"iShares China Large-Cap ETF\">FXI</a> <font color=\"green\">+3.95%</font>. <a href=\"https://seekingalpha.com/symbol/gaz\" title=\"iPath DJ-UBS Natural Gas Total Return Sub-Index ETN\">GAZ</a> <font color=\"green\">+3.72%</font>. <a href=\"https://seekingalpha.com/symbol/ura\" title=\"Global X Uranium ETF\">URA</a> <font color=\"green\">+3.58%</font>. <a href=\"https://seekingalpha.com/symbol/ung\" title=\"The United States Natural Gas ETF, LP\">UNG</a> <font color=\"green\">+3.21%</font>. <a href=\"https://seekingalpha.com/symbol/fcg\" title=\"First Trust ISE-Revere Natural Gas Index ETF\">FCG</a> <font color=\"green\">+2.51%</font>.</li>     <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/gdxj\" title=\"Market Vectors Junior Gold Miners ETF\">GDXJ</a> <font color=\"red\">-9.76%</font>. <a href=\"https://seekingalpha.com/symbol/gdx\" title=\"Market Vectors Gold Miners ETF\">GDX</a> <font color=\"red\">-7.79%</font>. <a href=\"https://seekingalpha.com/symbol/vxx\" title=\"iPath S&amp;P 500 VIX Short-Term Futures ETN\">VXX</a> <font color=\"red\">-5.53%</font>. <a href=\"https://seekingalpha.com/symbol/pslv\" title=\"Sprott Physical Silver Trust\">PSLV</a> <font color=\"red\">-5.28%</font>. <a href=\"https://seekingalpha.com/symbol/slv\" title=\"iShares Silver Trust ETF\">SLV</a> <font color=\"red\">-4.35%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429451\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$FXI $GAZ-OLD $URA - Weekly ETF Gainers / Losers https://seekingalpha.com/news/1429451-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1429451-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429371\" data-ts=\"1385153940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WETF\" target=\"_blank\">WETF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429371-wisdomtree-flies-after-ishares-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WisdomTree flies after iShares delay</a></h4><ul>\n<li>It's a big day for WisdomTree (<a href=\"https://seekingalpha.com/symbol/WETF\" title=\"WisdomTree Investments, Inc.\">WETF</a> <font color=\"green\">+7.7%</font>) after filings show iShares' (<a href=\"https://seekingalpha.com/symbol/BLK\" title=\"BlackRock, Inc.\">BLK</a> <font color=\"green\">+0.1%</font>) plan to launch a set of currency-hedged ETFs<a href=\"http://blogs.barrons.com/focusonfunds/2013/11/22/whys-wisdomtree-surging-8-try-a-delayed-blackrock-threat/\" target=\"_blank\"> is delayed</a> - now \"a 2014 story,\" says Susquehanna's Doug Sipkin.</li>\n<li>A big force behind WisdomTree's more than doubling in price this year is the runaway success of its currency-hedged Japan ETF (DXJ), and the delay from iShares gives it more time to wrack up assets at a time when the yen has renewed its downtrend and Japanese shares have resumed going higher. WisdomTree also has currency-hedged funds for Europe, Germany, and Korea.</li>\n<li>It's party time right now, but Sipkin is cautious longer-term thanks to the scale and distribution iShares will bring to the space on its funds do get launched.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429371\" data-linked=\"WisdomTree flies after iShares delay\" data-tweet=\"$WETF $WETF $BLK - WisdomTree flies after iShares delay https://seekingalpha.com/news/1429371-wisdomtree-flies-after-ishares-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/1429371-wisdomtree-flies-after-ishares-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429351\" data-ts=\"1385153887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HQCL\" target=\"_blank\">HQCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429351-hanwha-solar-closing-higher-after-announcing-portuguese-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hanwha Solar closing higher after announcing Portuguese deal</a></h4><ul>\n<li>Hanwha (HSOL <font color=\"green\">+4%</font>) has supplied 12.9MW of solar modules to consortium Gransolar Hyperion for use in Portuguese solar parks. The company <a href=\"http://news.cision.com/martifer-solar/r/martifer-solar-and-hanwha-q-cells-korea-complete-a-17-8-mw-pv-project-in-portugal,c9491247\" target=\"_blank\">previously delivered</a> 17.8MW of modules for six Portuguese solar parks. (PR)</li>\n<li>Though still <strong><font color=\"green\">up 264%</font></strong> YTD, Hanwha has had a rough number, thanks to disappointing <a href=\"https://seekingalpha.com/currents/post/1405922\" target=\"_blank\">Q3 numbers</a> and news of a <a href=\"https://seekingalpha.com/currents/post/1415452\" target=\"_blank\">$70M stock offering</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429351\" data-linked=\"Hanwha Solar closing higher after announcing Portuguese deal\" data-tweet=\"$HQCL - Hanwha Solar closing higher after announcing Portuguese deal https://seekingalpha.com/news/1429351-hanwha-solar-closing-higher-after-announcing-portuguese-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1429351-hanwha-solar-closing-higher-after-announcing-portuguese-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429311\" data-ts=\"1385153203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429311-upside-for-biogen-gilead-may-be-hard-to-come-by-barrons\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upside for Biogen, Gilead may be hard to come by: Barron&#39;s</a></h4><ul>\n<li>\"At 25 and 27 times forward earnings respectively, Biogen (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"green\">+12.6%</font>) and Gilead (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"green\">+3.5%</font>) <a href=\"http://online.barrons.com/article/SB50001424053111904253404579214071260938270.html\" target=\"_blank\">trade at sharp premiums</a> to the broader stock market,\" writes Johanna Bennett for <em>Barron's</em>.</li>\n<li>Bennett says that despite good news for both <a href=\"https://seekingalpha.com/currents/search?query=tecfidera\" target=\"_blank\">Tecfidera</a> and <a href=\"https://seekingalpha.com/currents/search?query=sofosbuvir\" target=\"_blank\">sofosbuvir</a> Friday, it's \"tough to make the case for putting new money to work at these levels.\"</li>\n<li>Further gains for BIIB hinge on \"a steady stream of good news out of the pipeline,\" and GILD faces competition in the all-oral HCV space, Bennett adds.</li>\n<li>Long story short, <em>Barron's</em> recommends ringing the register to lock in gains.</li>\n<li>For the counterpoint on BIIB, see <a href=\"https://seekingalpha.com/currents/post/1429041\" target=\"_blank\">here</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429311\" data-linked=\"Upside for Biogen, Gilead may be hard to come by: Barron&#39;s\" data-tweet=\"$BIIB $BIIB $GILD - Upside for Biogen, Gilead may be hard to come by: Barron&#39;s https://seekingalpha.com/news/1429311-upside-for-biogen-gilead-may-be-hard-to-come-by-barrons?source=tweet\" data-url=\"https://seekingalpha.com/news/1429311-upside-for-biogen-gilead-may-be-hard-to-come-by-barrons\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429261\" data-ts=\"1385151744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429261-zogenix-surges-cco-buys-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zogenix surges, CCO buys shares</a></h4><ul><li>Zogenix (<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a> <font color='green'>+10.9%</font>) posts double-digit gains on the session.</li><li>An SEC filing shows Chief Commercial Officer Richard Scott Shively (and his spouse) recently bought some 67K shares for around $187K. (<a href=\"http://archive.fast-edgar.com/20131121/Aabso5ngb-A-iQGdo-kwWIFp-jQdn/\" target=\"_blank\">FORM 4</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"1429261\" data-linked=\"Zogenix surges, CCO buys shares\" data-tweet=\"$ZGNX - Zogenix surges, CCO buys shares https://seekingalpha.com/news/1429261-zogenix-surges-cco-buys-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/1429261-zogenix-surges-cco-buys-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429241\" data-ts=\"1385151668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429241-analyst-potash-industry-endgame-nears-potash-and-mosaic-to-benefit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst: Potash industry endgame nears, Potash and Mosaic to benefit</a></h4><ul>     <li>The <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/11/22/the-potash-mosaic-endgame\" target=\"_blank\">end of the uncertainty</a> weighing on Potash (POT <font color=\"green\">+0.1%</font>) and Mosaic (<a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"green\">+2.2%</font>) may be at hand, J.P. Morgan analyst Jeffrey Zekauskas writes, believing the point of Uralkali's (<a href=\"https://seekingalpha.com/symbol/URALL\" title=\"Uralkali Jsc 144 A\">OTC:URALL</a>) ownership change is the alteration of its go-to-market strategy, and an execution of a change in strategy should raise the value of POT and MOS given their sensitivity to changes in product prices.</li>     <li>POT and MOS are \"undervalued,\" the firm says: Both companies have replacement values nearly twice their current share prices, POT has a 7.5%-8% sustainable free cash flow yield following the conclusion of its large potash capacity expansion, and MOS has a large share repurchase program it plans to execute beginning at the end of this month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1429241\" data-linked=\"Analyst: Potash industry endgame nears, Potash and Mosaic to benefit\" data-tweet=\"$NTR $NTR $MOS - Analyst: Potash industry endgame nears, Potash and Mosaic to benefit https://seekingalpha.com/news/1429241-analyst-potash-industry-endgame-nears-potash-and-mosaic-to-benefit?source=tweet\" data-url=\"https://seekingalpha.com/news/1429241-analyst-potash-industry-endgame-nears-potash-and-mosaic-to-benefit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429231\" data-ts=\"1385151076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429231-mortgage-reits-continue-to-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mortgage REITs continue to slide</a></h4><ul>\n<li>A nice backup in rates (the 10-year Treasury yield is off 4 bps to 2.75%) is of no help to the mortgage REITs (<a href=\"https://seekingalpha.com/symbol/REM\" title=\"iShares Mortgage Real Estate Capped ETF\">REM</a> <font color=\"red\">-0.3%</font>), with sector kingpins Annaly (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"red\">-1.4%</font>) and American Capital Agency (<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a> <font color=\"red\">-1.2%</font>) both hunkered down (NLY <a href=\"https://seekingalpha.com/currents/post/1396492\" target=\"_blank\">earnings call</a>, AGNC <a href=\"https://seekingalpha.com/currents/post/1364992\" target=\"_blank\">earnings call</a>) for the Fed taper, and both hitting 52-week lows today.</li>\n<li>Earlier this week, AGNC and <a href=\"https://seekingalpha.com/symbol/MTGE\" title=\"MTGE Investment Corp.\">MTGE</a> CIO Gary Kain took his case all the way to Asia at the Citi financial services conference in Hong Kong (<a href=\"https://seekingalpha.com/article/1852991-american-capital-agencys-management-presents-at-citi-global-financial-conference-transcript?source=feed_t\" target=\"_blank\">transcript</a>). Yes, book value has been hit by higher rates, but also by how much the market is willing to pay for it. Whereas AGNC traded at an average of 110%-120% of book over the past 4-5 years, it's now at sub-90%.</li>\n<li>Discounts can last for awhile, he admits, but also reminds this isn't some opaque bank balance sheet, but instead an easily valued, highly liquid portfolio of assets trading at $0.85-$0.90 on the dollar. As long as it persists, American Capital will continue selling MBS for $1 and buying back stock at a discount.</li>\n<li>Previous: Kain <a href=\"https://seekingalpha.com/currents/post/1410952\" target=\"_blank\">makes a similar case</a>\n</li>\n<li>Related ETFs: <a href=\"https://seekingalpha.com/symbol/MORT\" title=\"VanEck Vectors Mortgage REIT Income ETF\">MORT</a>, <a href=\"https://seekingalpha.com/symbol/MORL\" title=\"UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN\">MORL</a>\n</li>\n<li>Other sector stocks: Armour (<a href=\"https://seekingalpha.com/symbol/ARR\" title=\"ARMOUR Residential REIT, Inc.\">ARR</a>), Two Harbors (<a href=\"https://seekingalpha.com/symbol/TWO\" title=\"Two Harbors Investment Corp.\">TWO</a> <font color=\"red\">-0.8%</font>), CYS (<a href=\"https://seekingalpha.com/symbol/CYS\" title=\"CYS Investments, Inc.\">CYS</a> <font color=\"green\">+0.1%</font>), AG Mortgage (<a href=\"https://seekingalpha.com/symbol/MITT\" title=\"AG Mortgage Investment Trust, Inc.\">MITT</a> <font color=\"red\">-0.5%</font>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429231\" data-linked=\"Mortgage REITs continue to slide\" data-tweet=\"$NLY $REM $NLY - Mortgage REITs continue to slide https://seekingalpha.com/news/1429231-mortgage-reits-continue-to-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/1429231-mortgage-reits-continue-to-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429181\" data-ts=\"1385149561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLMT\" target=\"_blank\">CLMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429181-calumet-specialty-products-plus-1_8-percent-after-pricing-upsized-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calumet Specialty Products +1.8% after pricing upsized debt offering</a></h4><ul>     <li>Calumet Specialty Products (<a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a> <font color=\"green\">+1.8%</font>) units are moving after the MLP last night priced an upsized, $350M private placement of 7.625% senior unsecured notes due 2022.</li>     <li>The deal, which was increased 55% from initial plans for a $225M offering, is expected to close Nov. 26.</li>     <li>CLMT plans to use net proceeds for general partnership purposes, including working capital and possible acquisitions as well as buying back ~$100M of its 9.375% senior unsecured notes maturing in 2019 through privately negotiated transactions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1429181\" data-linked=\"Calumet Specialty Products +1.8% after pricing upsized debt offering\" data-tweet=\"$CLMT - Calumet Specialty Products +1.8% after pricing upsized debt offering https://seekingalpha.com/news/1429181-calumet-specialty-products-plus-1_8-percent-after-pricing-upsized-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1429181-calumet-specialty-products-plus-1_8-percent-after-pricing-upsized-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429151\" data-ts=\"1385149135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429151-cable-merger-mania-gets-even-wilder-after-joint-chtr-cmcsa-bid-for-twc-reported\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cable merger mania gets even wilder after joint CHTR-CMCSA bid for TWC reported</a></h4><ul> <li>Comcast (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+5%</font>) and Charter Communications (<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a> <font color='green'>+5.6%</font>) are <a href=\"https://twitter.com/BloombergTV/status/403968448176603136\" target=\"_blank\">reported</a> to be considering a joint bid for Time Warner Cable (TWC <font color='green'>+9.6%</font>).</li> <li>All three stocks have popped off the news.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1429151\" data-linked=\"Cable merger mania gets even wilder after joint CHTR-CMCSA bid for TWC reported\" data-tweet=\"$CMCSA $CMCSA $CHTR - Cable merger mania gets even wilder after joint CHTR-CMCSA bid for TWC reported https://seekingalpha.com/news/1429151-cable-merger-mania-gets-even-wilder-after-joint-chtr-cmcsa-bid-for-twc-reported?source=tweet\" data-url=\"https://seekingalpha.com/news/1429151-cable-merger-mania-gets-even-wilder-after-joint-chtr-cmcsa-bid-for-twc-reported\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429091\" data-ts=\"1385148073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDC\" target=\"_blank\">RDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429091-rowan-signs-10-year-rig-extension-with-saudi-aramco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rowan signs 10-year rig extension with Saudi Aramco</a></h4><ul>     <li>In its monthly fleet contract status report, Rowan Cos. (<a href=\"https://seekingalpha.com/symbol/RDC\" title=\"Rowan Companies plc\">RDC</a> <font color=\"red\">-1.6%</font>) reveals the Bob Keller rig was awarded a 10-year extension with Saudi Aramco in the Middle East commencing in May 2014 at $177.5K/day, above its previous day rate of $127.5K.</li>     <li>Also, its EXL I rig was awarded a one-year contract with Petronas in Indonesia  that commenced at the end of Oct. 2013 at $160K/day, in line  with the previous day rate.</li>\n<li>However, three other rigs reported increased Q4 2013 and Q1 2014 off rate time due to repairs, upgrades and inspections.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1429091\" data-linked=\"Rowan signs 10-year rig extension with Saudi Aramco\" data-tweet=\"$RDC - Rowan signs 10-year rig extension with Saudi Aramco https://seekingalpha.com/news/1429091-rowan-signs-10-year-rig-extension-with-saudi-aramco?source=tweet\" data-url=\"https://seekingalpha.com/news/1429091-rowan-signs-10-year-rig-extension-with-saudi-aramco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429071\" data-ts=\"1385147899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429071-summer-street-talks-amarin-vascepa-amid-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summer Street talks Amarin, Vascepa amid sell-off</a></h4><ul>\n<li>As the stock sells-off on this morning's <a href=\"https://seekingalpha.com/currents/post/1427821\" target=\"_blank\">FDA news</a>, Summer Street is out with <a href=\"http://www.streetinsider.com/Analyst+Comments/Amarin%27s+%28AMRN%29+Vascepa+in+Difficult+Spot%2C+Thinks+Summer+Street/8917750.html\" target=\"_blank\">some commentary</a> on Amarin (<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a> <font color=\"red\">-10.3%</font>).</li>\n<li>\"We believe that AMRN has almost no chance of getting the FDA to  approve <a href=\"https://seekingalpha.com/currents/search?query=vascepa\" target=\"_blank\">Vascepa</a> for treating moderate triglycerides without outcomes  data,\" Bart Classen says.</li>\n<li>\"A positive outcome trial is a long shot because no agent has ever shown an outcome benefit over statins.\" the analyst adds for good measure.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429071\" data-linked=\"Summer Street talks Amarin, Vascepa amid sell-off\" data-tweet=\"$AMRN - Summer Street talks Amarin, Vascepa amid sell-off https://seekingalpha.com/news/1429071-summer-street-talks-amarin-vascepa-amid-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/1429071-summer-street-talks-amarin-vascepa-amid-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429061\" data-ts=\"1385147293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLB\" target=\"_blank\">SLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429061-schlumbergers-credit-rating-lifted-at-s-and-p\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schlumberger&#39;s credit rating lifted at S&amp;P</a></h4><ul>     <li>Standard &amp; Poor\u2019s <a href=\"http://www.standardandpoors.com/prot/ratings/articles/en/us/?articleType=HTML&amp;assetID=1245360536958\" target=\"_blank\">raises its corporate credit rating</a> on Schlumberger (<a href=\"https://seekingalpha.com/symbol/SLB\" title=\"Schlumberger Limited\">SLB</a> <font color=\"green\">+1.8%</font>) one notch to AA- from A+, saying the company\u2019s competitive advantage and profitability are superior to peers.</li>     <li>S&amp;P cites SLB's \"leading position in the global oilfield markets, substantial geographic diversification, broad and technologically complex product and service offerings, and excellent relationships with the large oil companies.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1429061\" data-linked=\"Schlumberger&#39;s credit rating lifted at S&amp;P\" data-tweet=\"$SLB - Schlumberger&#39;s credit rating lifted at S&amp;P https://seekingalpha.com/news/1429061-schlumbergers-credit-rating-lifted-at-s-and-p?source=tweet\" data-url=\"https://seekingalpha.com/news/1429061-schlumbergers-credit-rating-lifted-at-s-and-p\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1429001\" data-ts=\"1385145360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1429001-isis-pharmaceuticals-adds-higher-dose-cohort-to-sma-trial-shares-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Isis Pharmaceuticals adds higher dose cohort to SMA trial, shares rise</a></h4><ul>\n<li>Isis Pharmaceuticals (ISIS <font color=\"green\">+7.1%</font>) trades higher after the company says it is adding a 12 mg cohort to a Phase 1b/2a ISIS-SMNRx SMA study.</li>\n<li>The company says the infant 12 mg cohort has been initiated.</li>\n<li>Patient additions will \"not change [the company's] plan to report data on the first three cohorts by early next year,\" ISIS says. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1429001\" data-linked=\"Isis Pharmaceuticals adds higher dose cohort to SMA trial, shares rise\" data-tweet=\"$IONS - Isis Pharmaceuticals adds higher dose cohort to SMA trial, shares rise https://seekingalpha.com/news/1429001-isis-pharmaceuticals-adds-higher-dose-cohort-to-sma-trial-shares-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/1429001-isis-pharmaceuticals-adds-higher-dose-cohort-to-sma-trial-shares-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428981\" data-ts=\"1385144908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CY\" target=\"_blank\">CY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428981-cypress-rallies-as-cfo-discloses-15k-share-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cypress rallies as CFO discloses 15K-share purchase</a></h4><ul>\n<li>Cypress (<a href=\"https://seekingalpha.com/symbol/CY\" title=\"Cypress Semiconductor Corporation\">CY</a> <font color=\"green\">+4.8%</font>) CFO Brad Buss <a href=\"http://www.forbes.com/sites/dividendchannel/2013/11/22/top-buys-by-top-brass-cfo-busss-137k-bet-on-cy/\" target=\"_blank\">bought 15K shares</a> yesterday at $9.13.</li>\n<li>The purchase came with Cypress shares only moderately above their 52-week low of $8.61. The company <a href=\"https://seekingalpha.com/currents/post/1296082\" target=\"_blank\">issued a major warning</a> in September, and has been dealing with <a href=\"https://seekingalpha.com/currents/post/1403352\" target=\"_blank\">tough competition</a> from Synaptics in the touchscreen controller space.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428981\" data-linked=\"Cypress rallies as CFO discloses 15K-share purchase\" data-tweet=\"$CY - Cypress rallies as CFO discloses 15K-share purchase https://seekingalpha.com/news/1428981-cypress-rallies-as-cfo-discloses-15k-share-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/1428981-cypress-rallies-as-cfo-discloses-15k-share-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428961\" data-ts=\"1385144614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRLB\" target=\"_blank\">PRLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428961-proto-labs-dives-sa-contributor-questions-valuation-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proto Labs dives; SA contributor questions valuation, growth</a></h4><ul>\n<li>SA contributor <a href=\"https://seekingalpha.com/article/1857221-insiders-are-bailing-on-proto-labs-for-good-reasons\" target=\"_blank\">Keubiko</a> questions Proto Labs' (<a href=\"https://seekingalpha.com/symbol/PRLB\" title=\"Proto Labs\">PRLB</a> <font color=\"red\">-11.1%</font>) credentials as a 3D printing play - the company makes custom parts for industrial customers using machining/injection molding tools - and suggests the fact it has been classified as such \"reminds [him] a bit of the 1997-2000 period where any company that put an \"e\" in front of its name got an instant spike in share price.\"</li>\n<li>He also takes aim at Proto Labs' valuation (11x 2013E sales), and thinks the company needs to add nearly 6K unique product developers per year (rather than the 1.4K it has been adding) to justify its current multiples.</li>\n<li>The author also notes Proto Labs' U.S. sales (over 70% of revenue) only grew 1.5% Q/Q in Q3, and that <a href=\"https://seekingalpha.com/currents/post/1375142\" target=\"_blank\">departing</a> CEO Brad Cleveland has sold $78M worth of shares since the company's 2012 IPO.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428961\" data-linked=\"Proto Labs dives; SA contributor questions valuation, growth\" data-tweet=\"$PRLB - Proto Labs dives; SA contributor questions valuation, growth https://seekingalpha.com/news/1428961-proto-labs-dives-sa-contributor-questions-valuation-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/1428961-proto-labs-dives-sa-contributor-questions-valuation-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428881\" data-ts=\"1385143054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428881-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/ATRM\" title=\"Aetrium Incorporated\">OTC:ATRM</a> <font color=\"green\">+146%</font>. <a href=\"https://seekingalpha.com/symbol/PVG\" title=\"Pretium Resources Inc\">PVG</a> <font color=\"green\">+82%</font>. <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"green\">+43%</font>. <a href=\"https://seekingalpha.com/symbol/PTIX\" title=\"Protagenic Therapeutics, Inc.\">PTIX</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/SPLK\" title=\"Splunk Inc.\">SPLK</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/PEIX\" title=\"Pacific Ethanol, Inc.\">PEIX</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/MONT\" title=\"Montage Technology Group Limited\">MONT</a> <font color=\"green\">+17%</font>. CRME <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/PRPH\" title=\"ProPhase Labs, Inc.\">PRPH</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/PACB\" title=\"Pacific Biosciences of California\">PACB</a> <font color=\"green\">+14%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/VMEM\" title=\"Violin Memory, Inc.\">VMEM</a> <font color=\"red\">-47%</font>. <a href=\"https://seekingalpha.com/symbol/TFM\" title=\"The Fresh Market\">TFM</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/RITT\" title=\"RiT Technologies Ltd.\">OTC:RITT</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/DLIA\" title=\"dELiA*s, Inc.\">DLIA</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/CBMX\" title=\"CombiMatrix Corporation\">CBMX</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/TTS\" title=\"Tile Shop Holdings, Inc.\">TTS</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/TXTR\" title=\"Textura Corp.\">TXTR</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/DLLR\" title=\"DFC Global Corp.\">DLLR</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/GRVY\" title=\"GRAVITY Co., Ltd. - American depositary shares, each representing one\">GRVY</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/NAT\" title=\"Nordic American Tankers Limited\">NAT</a> <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1428881\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ATRM $PVG $ARIA - Midday Gainers / Losers https://seekingalpha.com/news/1428881-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1428881-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428871\" data-ts=\"1385142298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSVC\" target=\"_blank\">GSVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428871-gsv-capital-slips-as-violin-memory-crashes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSV Capital slips as Violin Memory crashes</a></h4><ul>\n<li>Enterprise flash storage hardware vendor Violin Memory, which GSV Capital (<a href=\"https://seekingalpha.com/symbol/GSVC\" title=\"GSV Capital\">GSVC</a> <font color=\"red\">-1.6%</font>) took a stake in prior to its IPO, has shed nearly half its value today after <a href=\"https://seekingalpha.com/currents/post/1427011\" target=\"_blank\">missing FQ3 estimates</a> and providing very weak <a href=\"https://seekingalpha.com/currents/post/1427081\" target=\"_blank\">FQ4 guidance</a>.</li>\n<li>GSV estimated its stake in Violin was worth $14.4M at the end of Q2 (5.8% of its NAV at the time). Violin, which delivered <a href=\"https://seekingalpha.com/currents/post/1302822\" target=\"_blank\">a poor IPO</a> on Sep. 27, wasn't among GSV's top-10 holdings at the end of Q3.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428871\" data-linked=\"GSV Capital slips as Violin Memory crashes\" data-tweet=\"$GSVC $SSSS - GSV Capital slips as Violin Memory crashes https://seekingalpha.com/news/1428871-gsv-capital-slips-as-violin-memory-crashes?source=tweet\" data-url=\"https://seekingalpha.com/news/1428871-gsv-capital-slips-as-violin-memory-crashes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428861\" data-ts=\"1385142296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LL\" target=\"_blank\">LL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428861-tilson-talks-lumber-liquidators-falls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilson talks, Lumber Liquidators falls</a></h4><ul> <li>Lumber Liquidators (<a href=\"https://seekingalpha.com/symbol/LL\" title=\"Lumber Liquidators Holdings, Inc.\">LL</a> <font color=\"red\">-7.4%</font>) is getting the business from Whitney Tilson at the <a href=\"https://investors.robinhood.org/speakers.php?speaker=tilson\" target=\"_blank\">Robin Hood Investors Conference</a>.</li> <li>Reports indicate the stock is being presented as the best short idea of Tilson's Kase Capital Management.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1428861\" data-linked=\"Tilson talks, Lumber Liquidators falls\" data-tweet=\"$LL - Tilson talks, Lumber Liquidators falls https://seekingalpha.com/news/1428861-tilson-talks-lumber-liquidators-falls?source=tweet\" data-url=\"https://seekingalpha.com/news/1428861-tilson-talks-lumber-liquidators-falls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428841\" data-ts=\"1385142029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNDC\" target=\"_blank\">LNDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428841-landec-minus-7_5-percent-on-downside-guidance-for-quarter-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Landec -7.5% on downside guidance for quarter, year</a></h4><ul>     <li>Landec (<a href=\"https://seekingalpha.com/symbol/LNDC\" title=\"Landec Corporation\">LNDC</a> <font color=\"red\">-7.5%</font>) is lower after issuing downside guidance for FQ2 (Nov.), seeing EPS of ~$0.13 vs. $0.21 analyst consensus due to severe shortages of produce resulting in much higher than projected costs for raw materials in its value-added vegetable business.</li>     <li>Issues mixed guidance for FY 2014 (May), seeing EPS higher by 0%-5% Y/Y to $0.70-$0.74 vs. $0.84 consensus and revenues up 6% Y/Y to $468M vs. $472M consensus.</li>\n<li>Feltl &amp; Co. cuts its share price target to $13.50 from $16; the firm is confident in LNDC's long-term outlook but the easiest  comparisons start to hit in FQ4, meaning the stock could languish  for a quarter (Briefing.com).</li> </ul><div class=\"tiny-share-widget\" data-id=\"1428841\" data-linked=\"Landec -7.5% on downside guidance for quarter, year\" data-tweet=\"$LNDC - Landec -7.5% on downside guidance for quarter, year https://seekingalpha.com/news/1428841-landec-minus-7_5-percent-on-downside-guidance-for-quarter-year?source=tweet\" data-url=\"https://seekingalpha.com/news/1428841-landec-minus-7_5-percent-on-downside-guidance-for-quarter-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428821\" data-ts=\"1385141743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428821-splunk-skyrockets-as-street-praises-earnings-guidance-growth-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk skyrockets as Street praises earnings, guidance, growth potential</a></h4><ul>\n<li>Analyst PTs are rising after Splunk (<a href=\"https://seekingalpha.com/symbol/SPLK\" title=\"Splunk Inc.\">SPLK</a> <font color=\"green\">+19.3%</font>) <a href=\"https://seekingalpha.com/currents/post/1426891\" target=\"_blank\">beat FQ3 estimates</a> and issued decent <a href=\"https://seekingalpha.com/currents/post/1427121\" target=\"_blank\">FQ4 guidance</a>. The sell-side is particularly enthusiastic about the growing number of applications for Splunk's machine data analytics software.</li>\n<li>\n<a href=\"http://news.investors.com/112213-680293-splunk-hits-new-high-after-q3-earnings-beat-expectations.htm\" target=\"_blank\">FBR:</a> \"Splunk is clearly in the right place at the right time ... we believe the company is well positioned to capitalize on its broad set of use cases (e.g. IT operations, applications management, security, etc.) and expanded product offerings.\"</li>\n<li>FBN calls Splunk \"the quintessential Big Data stock,\" and likes the fact both revenue growth (+51% Y/Y) and billings growth (+58%) accelerated from FQ2 levels. Pac Crest says its checks indicate Splunk has a number of $1M+ deals in the pipeline, and <a href=\"http://www.streetinsider.com/Analyst+Comments/Splunk+%28SPLK%29+Target+Raised+to+%2474+at+Wedbush/8917711.html\" target=\"_blank\">Webush</a> notes license growth was 47% even as a record portion of bookings (1/3) were recognized ratably rather than up-front.</li>\n<li>On the CC (<a href=\"https://seekingalpha.com/article/1856561-splunk-management-discusses-q3-2014-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), Splunk mentioned it closed 207 $100K+ deals in FQ3, up from 163 in FQ2, and that its Splunk Storm cloud analytics platform has added 1K+ projects since being <a href=\"https://seekingalpha.com/currents/post/1397062\" target=\"_blank\">made largely free</a> to developers in October.</li>\n<li>Management also talked up the potential for Splunk to be used by many non-IT personnel in 2014 thanks to the launch of <a href=\"http://www.splunk.com/view/SP-CAAAH8T\" target=\"_blank\">Splunk Enterprise 6</a> (has a simpler UI meant to enable non-IT use), and <a href=\"http://www.zdnet.com/splunk-awss-kinesis-can-expand-our-market-7000023499/\" target=\"_blank\">insisted</a> Amazon's new <a href=\"http://arstechnica.com/information-technology/2013/11/amazon-wades-into-big-data-streams-with-kinesis/\" target=\"_blank\">Kinesis service</a> (enables the real-time processing of large data streams) is an opportunity rather than a threat, since it \"gives more companies exposure to their [data] logs,\" which Splunk can analyze.</li>\n<li>Shares now trade at a steep 26x estimated FY14 (ends Jan. '14) sales, per Splunk's revised guidance.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428821\" data-linked=\"Splunk skyrockets as Street praises earnings, guidance, growth potential\" data-tweet=\"$SPLK - Splunk skyrockets as Street praises earnings, guidance, growth potential https://seekingalpha.com/news/1428821-splunk-skyrockets-as-street-praises-earnings-guidance-growth-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/1428821-splunk-skyrockets-as-street-praises-earnings-guidance-growth-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428791\" data-ts=\"1385141358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLLR\" target=\"_blank\">DLLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428791-dfc-global-minus-11-percent-after-pulling-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DFC Global -11% after pulling debt offering</a></h4><ul><li>\"Current market conditions\" forces a cancellation of the refinancing of some of DFC Global's (<a href=\"https://seekingalpha.com/symbol/DLLR\" title=\"DFC Global Corp.\">DLLR</a> <font color=\"red\">-11%</font>) debt - the company pulls its offering of senior notes, the proceeds of which were expected to finance a tender of existing paper, 10.375% senior notes due in 2016.</li></ul><div class=\"tiny-share-widget\" data-id=\"1428791\" data-linked=\"DFC Global -11% after pulling debt offering\" data-tweet=\"$DLLR - DFC Global -11% after pulling debt offering https://seekingalpha.com/news/1428791-dfc-global-minus-11-percent-after-pulling-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1428791-dfc-global-minus-11-percent-after-pulling-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428781\" data-ts=\"1385141260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAM\" target=\"_blank\">CAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428781-cameron-shares-suffer-from-chevrons-rosebank-suspension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cameron shares suffer from Chevron&#39;s Rosebank suspension</a></h4><ul>     <li>Cameron International (<a href=\"https://seekingalpha.com/symbol/CAM\" title=\"Cameron International Corporation\">CAM</a> <font color=\"red\">-2.2%</font>) slides lower after Chevron's (NYSE:<a href=\"https://seekingalpha.com/symbol/CVX\" title=\"Chevron Corporation\">CVX</a>) decision to <a href=\"https://seekingalpha.com/currents/post/1428381\" target=\"_blank\">defer its Rosebank project</a>; CAM had announced receipt of a $540M award from CVX for OneSubsea  during Q3.</li>     <li>CAM's total 2014 revenues from the Rosebank project are <a href=\"http://finance.yahoo.com/news/cameron-chevron-rosebank-award-171200078.html\" target=\"_blank\">estimated at ~$30M</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1428781\" data-linked=\"Cameron shares suffer from Chevron&#39;s Rosebank suspension\" data-tweet=\"$CAM $CAM $CVX - Cameron shares suffer from Chevron&#39;s Rosebank suspension https://seekingalpha.com/news/1428781-cameron-shares-suffer-from-chevrons-rosebank-suspension?source=tweet\" data-url=\"https://seekingalpha.com/news/1428781-cameron-shares-suffer-from-chevrons-rosebank-suspension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428771\" data-ts=\"1385140562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GST\" target=\"_blank\">GST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428771-gastar-plus-11-percent-after-reporting-strong-hunton-limestone-flow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gastar +11% after reporting strong Hunton Limestone flow</a></h4><ul>     <li>Gastar Exploration (<a href=\"https://seekingalpha.com/symbol/GST\" title=\"Gastar Exploration Inc.\">GST</a> <font color=\"green\">+11.2%</font>) powers higher after reporting strong oil flows from a well targeting the Hunton Limestone in Oklahoma.</li>     <li>GST says the Mid-Con 6H well in the play reached a  peak  24-hour gross initial production rate of 1,442 boe/day and averaged 1,133 boe/day (86% crude  oil) during  the last 10 days.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1428771\" data-linked=\"Gastar +11% after reporting strong Hunton Limestone flow\" data-tweet=\"$GST - Gastar +11% after reporting strong Hunton Limestone flow https://seekingalpha.com/news/1428771-gastar-plus-11-percent-after-reporting-strong-hunton-limestone-flow?source=tweet\" data-url=\"https://seekingalpha.com/news/1428771-gastar-plus-11-percent-after-reporting-strong-hunton-limestone-flow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428721\" data-ts=\"1385139489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XEC\" target=\"_blank\">XEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428721-cimarex-plus-2-percent-on-stifel-upgrade-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cimarex +2% on Stifel upgrade to Buy</a></h4><ul>     <li>Cimarex Energy (<a href=\"https://seekingalpha.com/symbol/XEC\" title=\"Cimarex Energy Co.\">XEC</a> <font color=\"green\">+2.1%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4102607/update-stifel-upgrades-cimarex-energy-on-good-entry-poin\" target=\"_blank\">upgraded to Buy</a> from Hold with a $120 price target at Stifel, which believes the pullback in the shares over the past two months provides a good entry point ahead of what should be an increasing and very active Delaware Basin Permian test program in 2014.</li>     <li>In addition, the firm believes there is upside potential to 2014 consensus estimates.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1428721\" data-linked=\"Cimarex +2% on Stifel upgrade to Buy\" data-tweet=\"$XEC - Cimarex +2% on Stifel upgrade to Buy https://seekingalpha.com/news/1428721-cimarex-plus-2-percent-on-stifel-upgrade-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1428721-cimarex-plus-2-percent-on-stifel-upgrade-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428701\" data-ts=\"1385138838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOMO\" target=\"_blank\">GOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428701-chinese-app-developer-sungy-mobile-posts-strong-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese app developer Sungy Mobile posts strong IPO</a></h4><ul>\n<li>Though Sungy Mobile's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GOMO\" title=\"Sungy Mobile Limited\">GOMO</a>) IPO performance isn't quite as impressive as <a href=\"https://seekingalpha.com/currents/post/1428441\" target=\"_blank\">500.com's</a>, investors likely aren't complaining. After pricing its 7M-share offering at $11.22 (within a range of $9.50-$11.50), shares opened at $14.11 and are currently at $15.90, <strong><font color=\"green\">up 42%</font></strong>.</li>\n<li>That gives the prolific Chinese mobile app developer a valuation of $552M, or perhaps ~10x 2013 sales (given the company's recent sales growth).</li>\n<li>\n<a href=\"http://www.sec.gov/Archives/edgar/data/1584133/000119312513449556/d573845df1a.htm\" target=\"_blank\">F-1</a>, <a href=\"https://seekingalpha.com/article/1856801-ipo-preview-sungy-mobile\" target=\"_blank\">IPO preview</a>, <a href=\"https://seekingalpha.com/currents/post/1347932\" target=\"_blank\">more details</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428701\" data-linked=\"Chinese app developer Sungy Mobile posts strong IPO\" data-tweet=\"$GOMO - Chinese app developer Sungy Mobile posts strong IPO https://seekingalpha.com/news/1428701-chinese-app-developer-sungy-mobile-posts-strong-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/1428701-chinese-app-developer-sungy-mobile-posts-strong-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428651\" data-ts=\"1385138184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428651-intel-adds-to-losses-as-street-mulls-investor-day-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel adds to losses as Street mulls investor day guidance</a></h4><ul>\n<li>Bernstein's <a href=\"http://blogs.barrons.com/techtraderdaily/2013/11/22/this-morning-weighing-intels-new-look-cable-on-fire-universal-loses/\" target=\"_blank\">Stacy Rasgon</a>, who has been bearish on Intel (<a href=\"https://seekingalpha.com/symbol/INTC\" title=\"Intel Corporation\">INTC</a> <font color=\"red\">-4.8%</font>) for some time. \"We could actually feel the cheer leach out of the room a bit during [CFO] Stacy Smiths\u2019s final presentation, as outlook for 2014 (mostly flat on revenues, gross margins, operating income, and capex) was likely not quite as good as some had hoped.\"</li>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+EPS+View/Getting+Bullish+on+Intel+%28INTC%29%3F+Inconceivable%21+-+Goldman+Sachs/8917655.html\" target=\"_blank\">Goldman</a> (Sell) isn't pleased with Intel's <a href=\"https://seekingalpha.com/currents/post/1427461\" target=\"_blank\">guidance</a> for flat 2014 revenue/EPS growth, nor with its steep capex budget (~$11B). It also thinks the revenue forecast could be aggressive since it \"assumes no negative impact from the end of the corporate [PC] refresh cycle,\" and also assumes a pickup in server CPU division growth to a low-teens rate.</li>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Intel+%28INTC%29+Analyst+Day+Viewed+as+a+Catalyst%2C+Price+Target+Raised+-+Jefferies/8917340.html\" target=\"_blank\">Jefferies</a>, however, is lifting its PT to $32. \"Intel's message was compelling: its product line is geared to the new market reality, PCs are <a href=\"https://seekingalpha.com/currents/post/1426511\" target=\"_blank\">stabilizing</a>, servers are growing, and it <a href=\"https://seekingalpha.com/currents/post/1426461\" target=\"_blank\">expects to grow</a> its tablet MPU shipments by 4x to 40m units in 2014.\"</li>\n<li>SA contributor and Intel bull <a href=\"https://seekingalpha.com/article/1856971-intels-mobile-roadmap-is-incredibly-strong\" target=\"_blank\">Ashraf Eassa</a> is upbeat about the pending launch of Intel's dual-core Merrifield Atom smartphone CPU, the 2H14 launch of its 14nm Cherry Trail Atom tablet CPU (Bay Trail's successor), and (especially) the 2015 launch of its Broxton smartphone/tablet CPUs.</li>\n<li>Perhaps the biggest issue weighing on investors' minds: While keeping capex high to maintain its manufacturing edge, Intel is trying to offset <a href=\"https://seekingalpha.com/currents/post/1427371\" target=\"_blank\">declining</a> sales of Core PC CPUs by ramping sales of Atom CPUs that often have <a href=\"https://seekingalpha.com/currents/post/1329222\" target=\"_blank\">far lower ASPs</a>, and which some think could end up <a href=\"https://seekingalpha.com/currents/post/1022701\" target=\"_blank\">cannibalizing</a> low-end Core sales.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428651\" data-linked=\"Intel adds to losses as Street mulls investor day guidance\" data-tweet=\"$INTC - Intel adds to losses as Street mulls investor day guidance https://seekingalpha.com/news/1428651-intel-adds-to-losses-as-street-mulls-investor-day-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1428651-intel-adds-to-losses-as-street-mulls-investor-day-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428641\" data-ts=\"1385137530\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRXI\" target=\"_blank\">PRXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428641-premier-surges-as-board-pay-is-slashed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premier surges as board pay is slashed</a></h4><ul>\n<li>Premier Exhibitions (<a href=\"https://seekingalpha.com/symbol/PRXI\" title=\"Premier Exhibitions, Inc.\">OTC:PRXI</a> <font color=\"green\">+12.9%</font>) continues a nice move after management gives a hint of listening to disgruntled shareholders, lowering board compensation for non-employee directors to $50K per year - half in cash, half in stock - from $90K in cash previously. Chairman Mark Sellers will not receive any compensation.</li>\n<li>This brings annual board compensation down from $450K in cash to $125K in cash and $125K in stock. \"Given the recent decline in the share price, we realize there is a lot more work for us to do. We ask shareholders to remain patient and to stay tuned for more important announcements in the near future.\"</li>\n<li>The company also announces a total of 387,307 shares repurchased at an average price of $1.3057 (after the big move this week, the stock's back to $1.31).</li>\n<li>Previous: The FQ2 earnings call (<a href=\"https://seekingalpha.com/article/1737732-premier-exhibitions-ceo-discusses-f2q-2014-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>) following <a href=\"https://seekingalpha.com/currents/post/1321722\" target=\"_blank\">the collapse</a> of the Titanic sale deal is popcorn-worthy.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428641\" data-linked=\"Premier surges as board pay is slashed\" data-tweet=\"$PRXI - Premier surges as board pay is slashed https://seekingalpha.com/news/1428641-premier-surges-as-board-pay-is-slashed?source=tweet\" data-url=\"https://seekingalpha.com/news/1428641-premier-surges-as-board-pay-is-slashed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428631\" data-ts=\"1385137471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISH\" target=\"_blank\">DISH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428631-pay-tv-rally-dont-forget-about-dish-network-and-directv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pay-TV rally: Don&#39;t forget about Dish Network and DirecTV</a></h4><ul> <li>Shares of Dish Network (<a href=\"https://seekingalpha.com/symbol/DISH\" title=\"DISH Network Corporation\">DISH</a> <font color=\"green\">+3.4%</font>) and DirecTV (<a href=\"https://seekingalpha.com/symbol/DTV\" title=\"DTE Energy Company Corporate Units Cons 1/20 of 1000 USD of Nom Nts + 1 PC\">DTV</a> <font color=\"green\">+2.4%</font>) are both shooting high as the <a href=\"https://seekingalpha.com/currents/post/1428391\" target=\"_blank\">focus</a> on mergers within the Pay-TV sector brings the satellite players into the discussion.</li> <li>On pre-nuptials: A marriage between the two companies could be more likely if a pair of cable giants does some of the heavy lifting with regulators.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1428631\" data-linked=\"Pay-TV rally: Don&#39;t forget about Dish Network and DirecTV\" data-tweet=\"$DISH $DISH $T - Pay-TV rally: Don&#39;t forget about Dish Network and DirecTV https://seekingalpha.com/news/1428631-pay-tv-rally-dont-forget-about-dish-network-and-directv?source=tweet\" data-url=\"https://seekingalpha.com/news/1428631-pay-tv-rally-dont-forget-about-dish-network-and-directv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428621\" data-ts=\"1385137358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428621-ackman-would-replace-short-puts-with-cds-if-herbalife-taken-private\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ackman would replace short, puts with CDS if Herbalife taken private</a></h4><ul>\n<li>\"In order for the company to be taken private, they need to get audited financial statements,\" Bill Ackman <a href=\"http://www.bloomberg.com/video/ackman-we-ll-take-herbalife-to-end-of-the-earth-ib3Wf571TcOTWOARJa1YQw.html?cmpid=yhoo\" target=\"_blank\">tells Bloomberg</a>, when asked about the possibility that Bill Stiritz and others may attempt to orchestrate an LBO for Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"green\">+5.2%</font>).</li>\n<li>It has \"something close to an $8B enterprise value, let's assume they paid $9.5-10B to offer shareholders a premium, they'd have to raise $5B in equity capital\" he continues, adding that he isn't \"sure Carl [Icahn] is a big believer in this business on a long-term basis.\"</li>\n<li>As for what happens if they find the equity and are able to issue bonds for the remainder for what would be a \"major LBO,\" Ackman says Pershing will \"replace the position with credit default swaps [and] will take [the fight] to the end of the earth.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428621\" data-linked=\"Ackman would replace short, puts with CDS if Herbalife taken private\" data-tweet=\"$HLF - Ackman would replace short, puts with CDS if Herbalife taken private https://seekingalpha.com/news/1428621-ackman-would-replace-short-puts-with-cds-if-herbalife-taken-private?source=tweet\" data-url=\"https://seekingalpha.com/news/1428621-ackman-would-replace-short-puts-with-cds-if-herbalife-taken-private\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428541\" data-ts=\"1385136093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDX\" target=\"_blank\">CLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428541-celldex-galena-look-to-close-week-with-big-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celldex, Galena look to close week with big gains</a></h4><ul>\n<li>Shares of Celldex Therapeutics (<a href=\"https://seekingalpha.com/symbol/CLDX\" title=\"Celldex Therapeutics, Inc\">CLDX</a> <font color=\"green\">+6.1%</font>) are moving sharply higher in morning trading.</li>\n<li>Helping the cause is SA contributor Smith on Stocks, who thinks a conference call set for Monday morning <a href=\"https://seekingalpha.com/article/1857211-celldex-tune-in-for-mondays-conference-call-on-rindopepimut\" target=\"_blank\">may provide</a> \"new insights into <a href=\"https://seekingalpha.com/currents/search?query=rindopepimut\" target=\"_blank\">rindopepimut</a> and perhaps cancer vaccines overall.\"</li>\n<li>The shares are up <font color=\"green\">12%</font> this week.</li>\n<li>Another biotech set to lock in a solid gain for the week is Galena Biopharma (GALE <font color=\"green\">+8.6%</font>) which, with today's move, is up <font color=\"green\">~25%</font> since Monday.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428541\" data-linked=\"Celldex, Galena look to close week with big gains\" data-tweet=\"$CLDX $CLDX $SLS - Celldex, Galena look to close week with big gains https://seekingalpha.com/news/1428541-celldex-galena-look-to-close-week-with-big-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/1428541-celldex-galena-look-to-close-week-with-big-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428531\" data-ts=\"1385136020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLED\" target=\"_blank\">OLED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428531-universal-display-falls-after-receiving-adverse-patent-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Display falls after receiving adverse patent ruling</a></h4><ul>\n<li>A European Patent Office panel has revoked Universal Display's (<a href=\"https://seekingalpha.com/symbol/OLED\" title=\"Universal Display Corporation\">OLED</a> <font color=\"red\">-6%</font>) '238 patent, which had been upheld in a lower EPO ruling. The patent covers organometallic iridium device architectures (relevant to OLEDs), and was challenged by Sumitomo, Merck, and BASF. (PR)</li>\n<li>Universal asserts the ruling is \"erroneous,\" and says it \"may seek to file a petition to review the matter.\" The company also says it has a pending European patent application in which it \"intends to pursue substantial patent coverage that is similar to that provided in related patents that have previously been issued in the other jurisdictions.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1376972\" target=\"_blank\">Universal obtained</a> favorable patent rulings from the EPO and the Japanese IP High Court last month.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428531\" data-linked=\"Universal Display falls after receiving adverse patent ruling\" data-tweet=\"$OLED - Universal Display falls after receiving adverse patent ruling https://seekingalpha.com/news/1428531-universal-display-falls-after-receiving-adverse-patent-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/1428531-universal-display-falls-after-receiving-adverse-patent-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428521\" data-ts=\"1385135556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVG\" target=\"_blank\">PVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428521-pretium-pushes-nearly-80-percent-higher-on-apparent-bulk-sample-success\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pretium pushes nearly 80% higher on apparent bulk sample success</a></h4><ul>\n<li>Pretium Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/PVG\" title=\"Pretium Resources Inc\">PVG</a>) continues to rip higher, now <font color=\"green\">+78.5%</font> after saying the gold recovered from a 10K-ton bulk sample taken at Valley of the Kings in British Columbia <a href=\"https://seekingalpha.com/currents/post/1428131\" target=\"_blank\">exceeded its target</a>.</li>\n<li>The data published today appear to show <a href=\"http://www.bloomberg.com/news/2013-11-22/pretium-jumps-after-gold-from-ore-sample-exceeds-target.html\" target=\"_blank\">gold grades of ~16 grams/ton</a> of ore, a GMP Securities analyst says, higher than the 13-gram level the firm expected.</li>\n<li>Despite today's gains, an options trader still buys 1,240 calls betting on the stock <a href=\"http://www.optioncast.com/stock-options-blog/options-news/pretium-resources-inc-pvg-91-today-option-trader-still-buys-1240-calls-betting-stock-rallying-30-january/\" target=\"_blank\">rallying another 30%</a> by mid-January.</li>\n<li>The news prompts BMO to <a href=\"http://www.streetinsider.com/Upgrades/BMO+Capital+Upgrades+Pretium+Resources+%28PVG%29+to+Outperform/8917490.html\" target=\"_blank\">upgrade</a> shares to Outperform.</li>\n<li>It's worth remembering that the stock has experienced some ups and downs; shares were cut in half just <a href=\"https://seekingalpha.com/currents/post/1320592\" target=\"_blank\">last month</a> after a dispute between the company and a contractor working on the project.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428521\" data-linked=\"Pretium pushes nearly 80% higher on apparent bulk sample success\" data-tweet=\"$PVG - Pretium pushes nearly 80% higher on apparent bulk sample success https://seekingalpha.com/news/1428521-pretium-pushes-nearly-80-percent-higher-on-apparent-bulk-sample-success?source=tweet\" data-url=\"https://seekingalpha.com/news/1428521-pretium-pushes-nearly-80-percent-higher-on-apparent-bulk-sample-success\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428501\" data-ts=\"1385135261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428501-workday-veeva-higher-following-positive-cramer-mentions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday, Veeva higher following positive Cramer mentions</a></h4><ul>\n<li>\n<a href=\"http://www.cnbc.com/id/101212109\" target=\"_blank\">Jim Cramer</a> talked up enterprise cloud software vendors Workday (<a href=\"https://seekingalpha.com/symbol/WDAY\" title=\"Workday\">WDAY</a> <font color=\"green\">+1.2%</font>) and Veeva (<a href=\"https://seekingalpha.com/symbol/VEEV\" title=\"Veeva Systems Inc.\">VEEV</a> <font color=\"green\">+5%</font>) software during last night's episode of <em>Mad Money</em>.</li>\n<li>He thinks Workday's rapid growth gives it more room to run in spite of the big gains it has posted since its Oct. '12 IPO, and suggests Veeva's r life sciences/pharmaceutical sales apps can make companies more efficient. \"Who knows how many high-priced non-revenue producing positions that can replace?\"</li>\n<li>Workday, which was hit by a <a href=\"https://seekingalpha.com/currents/post/1422931\" target=\"_blank\">Cowen downgrade</a> on Wednesday, delivers its FQ3 report on Monday. Veeva, <font color=\"green\">up 97%</font> from its Oct. <a href=\"https://seekingalpha.com/currents/post/1330282\" target=\"_blank\">IPO price</a> of $20 (but <font color=\"red\">down 20%</font> from its high of $49), reports on Dec. 5.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428501\" data-linked=\"Workday, Veeva higher following positive Cramer mentions\" data-tweet=\"$WDAY $WDAY $VEEV - Workday, Veeva higher following positive Cramer mentions https://seekingalpha.com/news/1428501-workday-veeva-higher-following-positive-cramer-mentions?source=tweet\" data-url=\"https://seekingalpha.com/news/1428501-workday-veeva-higher-following-positive-cramer-mentions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428471\" data-ts=\"1385134616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNCE\" target=\"_blank\">VNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428471-vince-holding-soars-in-debut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vince Holding soars in debut</a></h4><ul> <li>Vince Holding (NYSE:<a href=\"https://seekingalpha.com/symbol/VNCE\" title=\"Vince Holding Corp.\">VNCE</a>) opens trading at $29.50 to mark a 47.5% pop from where the apparel company priced itself this morning.</li> <li><a href=\"https://seekingalpha.com/currents/post/1428031\" target=\"_blank\">S-1</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"1428471\" data-linked=\"Vince Holding soars in debut\" data-tweet=\"$VNCE - Vince Holding soars in debut https://seekingalpha.com/news/1428471-vince-holding-soars-in-debut?source=tweet\" data-url=\"https://seekingalpha.com/news/1428471-vince-holding-soars-in-debut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428441\" data-ts=\"1385133937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBAI\" target=\"_blank\">WBAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428441-500-com-takes-off-following-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">500.com takes off following IPO</a></h4><ul>\n<li>After pricing its 5.8M-share IPO at $13, 500.com (NYSE:<a href=\"https://seekingalpha.com/symbol/WBAI\" title=\"500.com Limited\">WBAI</a>) opened at $20 and is now at $21.78, <strong><font color=\"green\">up 67.5%</font></strong>. The Chinese online sports lottery service provider a market cap of $719M, or 25x 2012 sales.</li>\n<li>58.com (<a href=\"https://seekingalpha.com/symbol/WUBA\" title=\"58.com Inc.\">WUBA</a> <font color=\"green\">+4.8%</font>), another recent <a href=\"https://seekingalpha.com/currents/post/1374952\" target=\"_blank\">successful</a> Chinese Internet IPO, might be seeing a sympathy move higher.</li>\n<li>\n<a href=\"http://www.sec.gov/Archives/edgar/data/1517496/000119312513447862/d138068df1a.htm\" target=\"_blank\">F-1</a>, <a href=\"https://seekingalpha.com/article/1856851-ipo-preview-500-com\" target=\"_blank\">IPO preview</a>, <a href=\"https://seekingalpha.com/currents/post/1347932\" target=\"_blank\">more details</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428441\" data-linked=\"500.com takes off following IPO\" data-tweet=\"$WBAI $WBAI $WUBA - 500.com takes off following IPO https://seekingalpha.com/news/1428441-500-com-takes-off-following-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/1428441-500-com-takes-off-following-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428411\" data-ts=\"1385133388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428411-thai-stocks-extend-losses-down-more-than-4-percent-on-the-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thai stocks extend losses, down more than 4% on the week</a></h4><ul><li>Thai stocks (<a href='https://seekingalpha.com/symbol/thd' title='iShares MSCI Thailand Capped ETF'>THD</a>, <a href='https://seekingalpha.com/symbol/tf' title='Thai Capital Fund'>TF</a>, <a href='https://seekingalpha.com/symbol/ttf' title='Thai Fund'>TTF</a>) suffer through <a href=\"https://seekingalpha.com/currents/post/1425591\" target=\"_blank\">another</a> rough session (that's four in a row), falling <font color='red'>1.2%</font> in Bangkok.</li><li>Foreign selling <a href=\"http://uk.reuters.com/article/2013/11/22/markets-southeastasia-stocks-idUKL4N0J70OK20131122\" target=\"_blank\">now totals</a> $983M for November, according to Reuters.</li><li>The SET now sits at its lowest level since September 6.</li></ul><div class=\"tiny-share-widget\" data-id=\"1428411\" data-linked=\"Thai stocks extend losses, down more than 4% on the week\" data-tweet=\"$THD $TF-OLD $TTF - Thai stocks extend losses, down more than 4% on the week https://seekingalpha.com/news/1428411-thai-stocks-extend-losses-down-more-than-4-percent-on-the-week?source=tweet\" data-url=\"https://seekingalpha.com/news/1428411-thai-stocks-extend-losses-down-more-than-4-percent-on-the-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428401\" data-ts=\"1385133089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428401-vringo-scores-indian-injunction-against-zte-shares-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vringo scores Indian injunction against ZTE, shares rally</a></h4><ul>\n<li>The High Court of Delhi has granted Vringo (VRNG <font color=\"green\">+4.1%</font>) an injunction against ZTE's (<a href=\"https://seekingalpha.com/symbol/ZTCOY\" title=\"Zte Corp. ADR\">OTCPK:ZTCOY</a>) Indian unit over the latter's alleged infringement of Vringo's '980 patent, which has been declared standards-essential for cdma2000 networks (such as the ones run by multiple Indian carriers). (PR)</li>\n<li>The injunction bars the ZTE unit from manufacturing, importing, or selling phones, infrastructure equipment, and other hardware deemed to be infringing the '980 patent.</li>\n<li>Standards-essential patents are typically licensed under <a href=\"http://en.wikipedia.org/wiki/Reasonable_and_non-discriminatory_licensing\" target=\"_blank\">FRAND terms</a>. Odds are ZTE will ask for such terms in the event it attempts to settle with Vringo.</li>\n<li>Vringo is <a href=\"https://seekingalpha.com/currents/post/1406802\" target=\"_blank\">also suing ZTE</a> in several other markets.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428401\" data-linked=\"Vringo scores Indian injunction against ZTE, shares rally\" data-tweet=\"$XSPA $XSPA $ZTCOY - Vringo scores Indian injunction against ZTE, shares rally https://seekingalpha.com/news/1428401-vringo-scores-indian-injunction-against-zte-shares-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/1428401-vringo-scores-indian-injunction-against-zte-shares-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428351\" data-ts=\"1385132329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMEM\" target=\"_blank\">VMEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428351-violin-memory-trounced-on-q3-results-and-guidance-3-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Violin Memory trounced on Q3 results and guidance, 3 downgrades</a></h4><ul>\n<li>Violin Memory (<a href=\"https://seekingalpha.com/symbol/VMEM\" title=\"Violin Memory, Inc.\">VMEM</a> <font color=\"red\">-43.3%</font>) shares continue to dive following <a href=\"https://seekingalpha.com/currents/post/1427081\" target=\"_blank\">abysmal Q3 results and guidance</a>.</li>\n<li>Adding fuel to the fire are <a href=\"http://www.streetinsider.com/stock_lookup_news.php?q=vmem&amp;type=analyst\" target=\"_blank\">downgrades </a>from IPO underwriters J.P. Morgan (Overweight to Neutral, PT to $5.50 from $9), Deutsche Bank (Buy to Hold, PT to $3.50 from $10), and Pacific Crest (Outperform to Perform).</li>\n<li>Deutsche analyst Chris Whitmore cited the Q3 revenue miss and weak Q4 guidance. VMEM is burning $27M in FCF a quarter and has not \"articulated a plan to reduce it,\" which suggests that it can survive 5 more quarters at the going rate.</li>\n<li>Problematically, \"Poor execution as a new public company &amp; its high cash burn rate challenge mgmt's credibility with investors, its ability to raise add'l capital &amp; VMEM's multiple will compress on substantially lowered expectations,\" Whitmore concludes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428351\" data-linked=\"Violin Memory trounced on Q3 results and guidance, 3 downgrades\" data-tweet=\"$VMEM - Violin Memory trounced on Q3 results and guidance, 3 downgrades https://seekingalpha.com/news/1428351-violin-memory-trounced-on-q3-results-and-guidance-3-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/1428351-violin-memory-trounced-on-q3-results-and-guidance-3-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428341\" data-ts=\"1385132311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428341-herbalife-trades-higher-as-ackman-underwhelms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herbalife trades higher as Ackman underwhelms</a></h4><ul>\n<li>After trading lower by as much as <font color=\"red\">2.4%</font> during Bill Ackman's presentation at the Robin Hood Investors Conference, Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"green\">+2.9%</font>) moves immediately into positive territory after the Pershing Square chief leaves the stage.</li>\n<li>Although Ackman raised familiar questions and concerns, investors weren't impressed.</li>\n<li>With buyback and LBO rumors circulating, the bar for what counts as \"bad news\" for the shares has been ratcheted ever-higher over the past several months.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428341\" data-linked=\"Herbalife trades higher as Ackman underwhelms\" data-tweet=\"$HLF - Herbalife trades higher as Ackman underwhelms https://seekingalpha.com/news/1428341-herbalife-trades-higher-as-ackman-underwhelms?source=tweet\" data-url=\"https://seekingalpha.com/news/1428341-herbalife-trades-higher-as-ackman-underwhelms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428321\" data-ts=\"1385131856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428321-ligand-rebounds-as-summer-street-strikes-upbeat-tone-on-kyprolis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ligand rebounds as Summer Street strikes upbeat tone on Kyprolis</a></h4><ul>\n<li>Summer Street is out with some <a href=\"http://www.streetinsider.com/Analyst+Comments/Ligand+Pharma+%28LGND%29+Target+Raised+to+%2469+at+Summer+Street/8917508.html\" target=\"_blank\">upbeat commentary</a> on Ligand Pharma (<a href=\"https://seekingalpha.com/symbol/LGND\" title=\"Ligand Pharmaceuticals Incorporated\">LGND</a> <font color=\"green\">+2.2%</font>) which is trading higher this morning after Thursday's weak session.</li>\n<li>Although Carol Werther acknowledges that \"LGND's EPS is dependent on royalties and milestones that are sometimes choppy and unpredictable,\" the analyst expects \"strong <a href=\"https://seekingalpha.com/currents/search?query=kyprolis\" target=\"_blank\">Kyprolis</a> sales as multiple myeloma patients refractory to first-line need treatment.\"</li>\n<li>As for the BofA/Merrill Lynch comments that <a href=\"https://seekingalpha.com/currents/post/1426661\" target=\"_blank\">sunk the shares</a> Thursday, Werther says \"there is no evidence that the side effects reported are different from the Kyprolis label.\"</li>\n<li>Price target hiked to $69 from $64.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428321\" data-linked=\"Ligand rebounds as Summer Street strikes upbeat tone on Kyprolis\" data-tweet=\"$LGND - Ligand rebounds as Summer Street strikes upbeat tone on Kyprolis https://seekingalpha.com/news/1428321-ligand-rebounds-as-summer-street-strikes-upbeat-tone-on-kyprolis?source=tweet\" data-url=\"https://seekingalpha.com/news/1428321-ligand-rebounds-as-summer-street-strikes-upbeat-tone-on-kyprolis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428311\" data-ts=\"1385131756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAX\" target=\"_blank\">RAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428311-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul><li>Rackspace (<a href='https://seekingalpha.com/symbol/RAX' title='Rackspace Hosting, Inc.'>RAX</a> <font color='red'>-2.6%</font>) has been started at Neutral by D.A. Davidson.</li><li>Take-Two (<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a> <font color='red'>-3.8%</font>) has been cut to Market Perform by Cowen.</li><li>Gogo (<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='red'>-1.9%</font>) has been <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+JPMorgan+Cuts+Gogo+%28GOGO%29+to+Neutral+as+Massive+Lockup+Expiration+Looms/8917052.html\" target=\"_blank\">cut to Neutral</a> by JPMorgan due to concerns about a Dec. 17 lockup expiration (67% of shares will be made available for sale).</li><li>ServiceSource (<a href='https://seekingalpha.com/symbol/SREV' title='ServiceSource International, Inc.'>SREV</a> <font color='green'>+3.5%</font>) has been upgraded to Buy by Credit Agricole.</li><li>Silicon Motion (<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a> <font color='green'>+3.4%</font>) has been started at Buy by BofA/Merrill.</li><li>Qiwi (<a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+4.4%</font>) has been started at Buy by Goldman shortly after <a href=\"https://seekingalpha.com/currents/post/1419851\" target=\"_blank\">beating</a> Q3 estimates and <a href=\"https://seekingalpha.com/currents/post/1420551\" target=\"_blank\">upping</a> its full-year guidance.</li></ul><div class=\"tiny-share-widget\" data-id=\"1428311\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$RAX $RAX $TTWO - A roundup of tech ratings changes https://seekingalpha.com/news/1428311-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1428311-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428301\" data-ts=\"1385131557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROST\" target=\"_blank\">ROST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428301-ross-stores-cant-find-a-way-around-heavy-discounting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ross Stores can&#39;t find a way around heavy discounting</a></h4><ul> <li>Ross Stores (<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a> <font color='red'>-8.2%</font>) crumbles after <a href=\"https://seekingalpha.com/currents/post/1427181\" target=\"_blank\">reporting</a> comparable store sales growth which was less than half of what peer TJX Companies recorded in Q3.</li> <li>The retailer has been bid up due to its long history of resiliency with consumer spending trends, but now it's butting up against its own tough comps amid heavy discounting in the sector.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1428301\" data-linked=\"Ross Stores can&#39;t find a way around heavy discounting\" data-tweet=\"$ROST - Ross Stores can&#39;t find a way around heavy discounting https://seekingalpha.com/news/1428301-ross-stores-cant-find-a-way-around-heavy-discounting?source=tweet\" data-url=\"https://seekingalpha.com/news/1428301-ross-stores-cant-find-a-way-around-heavy-discounting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428291\" data-ts=\"1385131172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIG\" target=\"_blank\">FIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428291-fortress-boosted-by-credit-suisse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortress boosted by Credit Suisse</a></h4><ul><li>Fortress (<a href=\"https://seekingalpha.com/symbol/FIG\" title=\"Fortress Investment Group LLC\">FIG</a> <font color=\"green\">+3.7%</font>) opens sharply higher after Credit Suisse says there's plenty of room to run for the stock, driven by incentive fees, accelerated capital deployment, a more diversified business model, and organic growth not yet priced in. The team ups its price target to $11 from $9.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"1428291\" data-linked=\"Fortress boosted by Credit Suisse\" data-tweet=\"$FIG - Fortress boosted by Credit Suisse https://seekingalpha.com/news/1428291-fortress-boosted-by-credit-suisse?source=tweet\" data-url=\"https://seekingalpha.com/news/1428291-fortress-boosted-by-credit-suisse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428281\" data-ts=\"1385130995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGL\" target=\"_blank\">MDGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428281-synta-pharmaceuticals-jumps-on-publication-of-ganetespib-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synta Pharmaceuticals jumps on publication of ganetespib results</a></h4><ul>\n<li>Synta Pharmaceuticals (SNTA <font color=\"green\">+4.2%</font>) moves higher in early trading.</li>\n<li>The shares are likely getting a lift from news that collaborators at Johns Hopkins and Duke's Dana-Farber Cancer Institute have separately published results which the company says \"demonstrate the ability of <a href=\"https://seekingalpha.com/currents/search?query=ganetespib\" target=\"_blank\">ganetespib</a> to down-regulate a       number of key proteins involved in tumor growth and metastasis.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428281\" data-linked=\"Synta Pharmaceuticals jumps on publication of ganetespib results\" data-tweet=\"$MDGL - Synta Pharmaceuticals jumps on publication of ganetespib results https://seekingalpha.com/news/1428281-synta-pharmaceuticals-jumps-on-publication-of-ganetespib-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1428281-synta-pharmaceuticals-jumps-on-publication-of-ganetespib-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428271\" data-ts=\"1385130976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428271-aetrium-plus-210-percent-on-2_1m-in-new-orders-as-low-market-cap-float-stoke-fire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aetrium +210% on $2.1M in new orders, as low market cap, float stoke fire</a></h4><ul><li>Aetrium (ATRM <strong><font color='green'>+210%) </font></strong>has doubled and then some, after the company announced yesterday afternoon it had <a href=\"https://seekingalpha.com/currents/post/1427351\" target=\"_blank\">received $2.1M in new orders</a> that it expects to deliver by Q1 2014.</li><li>The company's $5.8M in TTM revenue, yesterday's $3.3M market cap, and a float of 964K shares are all adding fuel to the fire.</li></ul><div class=\"tiny-share-widget\" data-id=\"1428271\" data-linked=\"Aetrium +210% on $2.1M in new orders, as low market cap, float stoke fire\" data-tweet=\"Aetrium +210% on $2.1M in new orders, as low market cap, float stoke fire https://seekingalpha.com/news/1428271-aetrium-plus-210-percent-on-2_1m-in-new-orders-as-low-market-cap-float-stoke-fire?source=tweet\" data-url=\"https://seekingalpha.com/news/1428271-aetrium-plus-210-percent-on-2_1m-in-new-orders-as-low-market-cap-float-stoke-fire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428261\" data-ts=\"1385130920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428261-us-steel-nucor-downgraded-at-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">US Steel, Nucor downgraded at Wells Fargo</a></h4><ul>     <li>U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"red\">-2.2%</font>) and Nucor (<a href=\"https://seekingalpha.com/symbol/NUE\" title=\"Nucor Corporation\">NUE</a> <font color=\"red\">-2.3%</font>) open lower after receiving <a href=\"http://www.streetinsider.com/Downgrades/Wells+Fargo+Cuts+US+Steel+%28X%29+to+Underperform%2C+Nucor+%28NUE%29+Cut+to+Market+Perform/8917026.html\" target=\"_blank\">downgrades</a> from Wells Fargo; X is cut to Underperform with a $17-$21 target range, as the firm thinks shares have been rewarded prematurely on cost-cutting measures, while NUE is dropped to Market Perform and a $50-$55 price target due mostly to valuation.</li>     <li>Steel stocks have enjoyed an impressive move thanks to a recovery in sheet prices, but the firm believes upside to near-term earnings estimates is  expected and the long trade likely will die once companies positively pre-announce results in December, and expects pricing to weaken meaningfully in H1 2014 due to increasing levels of import competition.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428261\" data-linked=\"US Steel, Nucor downgraded at Wells Fargo\" data-tweet=\"$X $X $NUE - US Steel, Nucor downgraded at Wells Fargo https://seekingalpha.com/news/1428261-us-steel-nucor-downgraded-at-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/1428261-us-steel-nucor-downgraded-at-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428231\" data-ts=\"1385130720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428231-3d-systems-partnering-with-motorola-to-create-custom-phones\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D Systems partnering with Motorola to create custom phones</a></h4><ul>\n<li>3D Systems (<a href=\"https://seekingalpha.com/symbol/DDD\" title=\"3D Systems Corp.\">DDD</a> <font color=\"green\">+5.7%</font>) has struck a multi-year deal with Motorola Mobility (<a href=\"https://seekingalpha.com/symbol/GOOG\" title=\"Alphabet, Inc. Cl C\">GOOG</a>) to support the latter's <a href=\"https://seekingalpha.com/currents/post/1364702\" target=\"_blank\">Project Ara</a>, an open-source initiative meant to enable custom smartphones for which users can mix and match various hardware components (the display, processor, memory, radios, etc.). (PR)</li>\n<li>3D is expected to make smartphone enclosures and modules for Ara, and act as Motorola's \"exclusive fulfillment partner\" for the project.</li>\n<li>Also: 3D and Motorola will create \"a continuous high-speed 3D printing production platform and fulfillment system,\" and 3D plans to \"substantially expand its multi-material printing capabilities\" to help make the project possible.</li>\n<li>If successful, Ara would represent a radical departure from how mobile phones have been manufactured for decades, and could offer consumers an unprecedented level of hardware customization. But the project will need to gain the backing of major component suppliers to make headway.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428231\" data-linked=\"3D Systems partnering with Motorola to create custom phones\" data-tweet=\"$DDD $DDD $GOOG - 3D Systems partnering with Motorola to create custom phones https://seekingalpha.com/news/1428231-3d-systems-partnering-with-motorola-to-create-custom-phones?source=tweet\" data-url=\"https://seekingalpha.com/news/1428231-3d-systems-partnering-with-motorola-to-create-custom-phones\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428221\" data-ts=\"1385130631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADC\" target=\"_blank\">ADC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428221-agree-realty-minus-5_8-percent-after-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agree Realty -5.8% after secondary</a></h4><ul>\n<li>Agree Realty (NYSE:<a href=\"https://seekingalpha.com/symbol/ADC\" title=\"Agree Realty Corporation\">ADC</a>) prices a 1.65M share secondary offering for gross proceeds of $49.2M (presumably about $29.82 per share). The underwriter greenshoe is 247.5K shares.</li>\n<li>The stock's <font color=\"red\">off 5.8%</font> to $28.80 premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428221\" data-linked=\"Agree Realty -5.8% after secondary\" data-tweet=\"$ADC - Agree Realty -5.8% after secondary https://seekingalpha.com/news/1428221-agree-realty-minus-5_8-percent-after-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/1428221-agree-realty-minus-5_8-percent-after-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428151\" data-ts=\"1385129571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428151-biogen-gets-nas-designation-for-tecfidera-in-eu\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen gets NAS designation for Tecfidera in EU</a></h4><ul>\n<li>Biogen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a>) wins a <a href=\"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001963.jsp&amp;mid=WC0b01ac058004d5c1\" target=\"_blank\">new active substance designation</a> for <a href=\"https://seekingalpha.com/currents/search?query=tecfidera\" target=\"_blank\">Tecfidera</a>.</li>\n<li>Investors have been watching this story closely, as an EU launch without regulatory data protection wasn't assured.</li>\n<li>The news removes a critical overhang from the shares and means generic competition will be kept at bay.</li>\n<li>In terms of quantifying the impact, <a href=\"https://twitter.com/ScalpIdeas/status/403884659026563072\" target=\"_blank\">market chatter</a> indicates Cowen thinks the NPV of Tecfidera (with exclusivity) in the EU is around $20/share, while Deutsche's Robyn Karnauskas <a href=\"https://seekingalpha.com/currents/post/1360992\" target=\"_blank\">put the figure</a> at ~$25 last month. <br>\n</li>\n<li>For more on why the decision was expected, see <a href=\"https://seekingalpha.com/currents/post/1426361\" target=\"_blank\">commentary</a> from Wells Fargo out Thursday.</li>\n<li>BIIB <strong><font color=\"green\">+9%</font></strong> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428151\" data-linked=\"Biogen gets NAS designation for Tecfidera in EU\" data-tweet=\"$BIIB - Biogen gets NAS designation for Tecfidera in EU https://seekingalpha.com/news/1428151-biogen-gets-nas-designation-for-tecfidera-in-eu?source=tweet\" data-url=\"https://seekingalpha.com/news/1428151-biogen-gets-nas-designation-for-tecfidera-in-eu\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428131\" data-ts=\"1385129041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVG\" target=\"_blank\">PVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428131-pretium-resources-plus-36_5-percent-premarket-as-bulk-sample-surpasses-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pretium Resources +36.5% premarket as bulk sample surpasses target</a></h4><ul>     <li>Pretium Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/PVG\" title=\"Pretium Resources Inc\">PVG</a>) <font color=\"green\">+36.5%</font> premarket after reporting 4,215 oz. of gold have been produced from the first 8K metric tons of excavated material in its bulk sample program at the Valley of the Kings in British Columbia, easily beats the target of 4K oz. of gold projected to be produced from the entire 10K metric tons of material excavated for  the program.</li>\n<li>Processing is continuing on track and is expected to be completed by the first week of December.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428131\" data-linked=\"Pretium Resources +36.5% premarket as bulk sample surpasses target\" data-tweet=\"$PVG - Pretium Resources +36.5% premarket as bulk sample surpasses target https://seekingalpha.com/news/1428131-pretium-resources-plus-36_5-percent-premarket-as-bulk-sample-surpasses-target?source=tweet\" data-url=\"https://seekingalpha.com/news/1428131-pretium-resources-plus-36_5-percent-premarket-as-bulk-sample-surpasses-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428051\" data-ts=\"1385127937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428051-ariad-gets-positive-chmp-opinion-for-continued-iclusig-availability\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ariad gets positive CHMP opinion for continued Iclusig availability</a></h4><ul>\n<li>The CHMP renders a positive opinion on the continued availability of Ariad's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a>) <a href=\"https://seekingalpha.com/currents/search?query=iclusig\" target=\"_blank\">Iclusig</a> for \"authorized indications\" (various phases of dasatinib or nilotinib-resistant CML, dasatinib-resistant Ph+ ALL, etc.)</li>\n<li>The EMA has also made a few recommendations regarding how to cut down on the risk of occlusive vascular events.</li>\n<li>Suggestions include: The drug should not be used by patients with a history of heart attack or stroke, patients' cardiovascular status should be assessed prior to treatment, hypertension should be controlled over the course of Iclusig treatment, and monitoring should be in place to detect vascular occlusion or         thromboembolism. (PR)</li>\n<li>ARIA <font color=\"green\">+28%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428051\" data-linked=\"Ariad gets positive CHMP opinion for continued Iclusig availability\" data-tweet=\"$ARIA - Ariad gets positive CHMP opinion for continued Iclusig availability https://seekingalpha.com/news/1428051-ariad-gets-positive-chmp-opinion-for-continued-iclusig-availability?source=tweet\" data-url=\"https://seekingalpha.com/news/1428051-ariad-gets-positive-chmp-opinion-for-continued-iclusig-availability\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1428011\" data-ts=\"1385126887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POZN\" target=\"_blank\">POZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1428011-investors-cheer-pozen-cash-distribution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors cheer Pozen cash distribution</a></h4><ul>\n<li>Pozen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/POZN\" title=\"Pozen, Inc.\">POZN</a>) jumps <font color=\"green\">15% </font>in premarket trading.</li>\n<li>Investors are cheering the company's <a href=\"https://seekingalpha.com/currents/post/1426941\" target=\"_blank\">special cash distribution</a> announced Thursday evening after the bell.<br>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1428011\" data-linked=\"Investors cheer Pozen cash distribution\" data-tweet=\"$POZN - Investors cheer Pozen cash distribution https://seekingalpha.com/news/1428011-investors-cheer-pozen-cash-distribution?source=tweet\" data-url=\"https://seekingalpha.com/news/1428011-investors-cheer-pozen-cash-distribution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1427991\" data-ts=\"1385126492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTR\" target=\"_blank\">CHTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1427991-time-warner-cable-higher-on-charter-buyout-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Time Warner Cable higher on Charter buyout talk</a></h4><ul> <li>Shares of Time Warner Cable (TWC) are active in premarket trading after Charter Communications (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CHTR\" title=\"Charter Communications, Inc.\">CHTR</a>) keeps <a href=\"https://seekingalpha.com/currents/post/1427531\" target=\"_blank\">hacking away</a> at putting together a deal to buy the cable player.</li> <li>Earlier this week, TWC CFO Arthur Minson didn't even give a glimmer of inspiration that the company would be receptive to an offer during his Q&amp;A at an investor conference.</li> <li>TWC <font color=\"green\">+5.5%</font> premarket to $127.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1427991\" data-linked=\"Time Warner Cable higher on Charter buyout talk\" data-tweet=\"$CHTR - Time Warner Cable higher on Charter buyout talk https://seekingalpha.com/news/1427991-time-warner-cable-higher-on-charter-buyout-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/1427991-time-warner-cable-higher-on-charter-buyout-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1427951\" data-ts=\"1385126021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANN\" target=\"_blank\">ANN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1427951-relaxed-loft-boosts-ann-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Relaxed Loft boosts Ann in Q3</a></h4><ul> <li>Ann (NYSE:<a href=\"https://seekingalpha.com/symbol/ANN\" title=\"Ann, Inc.\">ANN</a>) reports comparable store sales rose 3.7% in Q3 as the Loft brand had strong gains.</li> <li>Gross margin slipped 140 bps to 55.4% of net sales as the promotional retail environment and product mix factored in. (PR)</li> <li>ANN <font color=\"red\">-1.1%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1427951\" data-linked=\"Relaxed Loft boosts Ann in Q3\" data-tweet=\"$ANN - Relaxed Loft boosts Ann in Q3 https://seekingalpha.com/news/1427951-relaxed-loft-boosts-ann-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/1427951-relaxed-loft-boosts-ann-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1427901\" data-ts=\"1385125168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1427901-foot-locker-impresses-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foot Locker impresses again</a></h4><ul> <li>Foot Locker (NYSE:<a href=\"https://seekingalpha.com/symbol/FL\" title=\"Foot Locker, Inc.\">FL</a>) reports comparable-store sales increased 4.1% in Q3 which marks a <a href=\"https://twitter.com/Retail_Guru/status/403868229614829568\" target=\"_blank\">nice acceleration</a> from the 1.8% it delivered in Q2.</li> <li>Cost of sales rose 6.1% during the quarter.</li> <li>The company's total store count rose 5.2% to 3,510 led by international expansion. (PR)</li> <li>FL <font color=\"green\">+3.9%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1427901\" data-linked=\"Foot Locker impresses again\" data-tweet=\"$FL - Foot Locker impresses again https://seekingalpha.com/news/1427901-foot-locker-impresses-again?source=tweet\" data-url=\"https://seekingalpha.com/news/1427901-foot-locker-impresses-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1427841\" data-ts=\"1385124372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1427841-more-on-fda-amarin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on FDA - Amarin</a></h4><ul>   <li>Under the FDA's special protocol assessment (SPA) for the Anchor indication of Amarin's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a>) Vascepa treatment, the agency had said that the design of the associated Phase III trial was adequate to support a marketing application to broaden the use of the drug, which lowers triglyceride fat in blood.</li>    <li>The study was testing Vascepa in people who take statins to cut cholesterol and have a high risk of coronary heart disease. Vascepa is already used to reduce triglycerides in patients who don't take statins.</li>    <li>The FDA is <a href=\"http://www.reuters.com/article/2013/11/22/amarin-fda-vascepa-idUSL4N0J72MT20131122\" target=\"_blank\">due to decide</a> by December 20 whether to widen the authorization of Vascepa. However, given the latest developments and that an FDA advisory committee overwhelmingly voted against such approval, things are not looking promising.</li>    <li>Shares continue to tank and are <font color=\"red\">-17.5%</font>. (<a href=\"https://seekingalpha.com/currents/post/1427821\" target=\"_blank\">Previous</a>) (<a href=\"http://boardvote.com/symbol/AMRN/communique/493354\" target=\"_blank\">8K</a>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1427841\" data-linked=\"More on FDA - Amarin\" data-tweet=\"$AMRN - More on FDA - Amarin https://seekingalpha.com/news/1427841-more-on-fda-amarin?source=tweet\" data-url=\"https://seekingalpha.com/news/1427841-more-on-fda-amarin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1427831\" data-ts=\"1385124319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1427831-no-panic-from-gap-despite-retail-woes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">No panic from Gap despite retail woes</a></h4><ul> <li>Management at Gap (NYSE:<a href=\"https://seekingalpha.com/symbol/GPS\" title=\"The Gap, Inc.\">GPS</a>) ran a tight ship during Q3 as expenses fell 6% even with sales growth in place. The operating margin rate for Gap was up a full percentage point from a year ago.</li> <li>Though the retailer didn't break it down, the sluggish 1% rate of comp store growth appears to have been impacted by more promotions.</li> <li>Online sales rose 20% to $589M for the quarter.</li> <li>The company approved a $1B share repurchase plan.</li> <li>GPS <font color=\"green\">+1.2%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1427831\" data-linked=\"No panic from Gap despite retail woes\" data-tweet=\"$GPS - No panic from Gap despite retail woes https://seekingalpha.com/news/1427831-no-panic-from-gap-despite-retail-woes?source=tweet\" data-url=\"https://seekingalpha.com/news/1427831-no-panic-from-gap-despite-retail-woes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1427821\" data-ts=\"1385124274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1427821-fda-denies-amarins-anchor-spa-appeal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA denies Amarin&#39;s ANCHOR SPA appeal</a></h4><ul>\n<li>The FDA has not accepted Amarin's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a>) appeal regarding the rescission of the SPA for <a href=\"https://seekingalpha.com/currents/search?query=vascepa\" target=\"_blank\">Vascepa</a>'s ANCHOR study.</li>\n<li>The company also says its \"request for a meeting at a high level within the FDA regarding the appeal was not granted.\"</li>\n<li>AMRN says it plans to continue to pursue the appeal. (<a href=\"http://biz.yahoo.com/e/131122/amrn8-k.html\" target=\"_blank\">8-K</a>)</li>\n<li>AMRN <font color=\"red\">-12%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1427821\" data-linked=\"FDA denies Amarin&#39;s ANCHOR SPA appeal\" data-tweet=\"$AMRN - FDA denies Amarin&#39;s ANCHOR SPA appeal https://seekingalpha.com/news/1427821-fda-denies-amarins-anchor-spa-appeal?source=tweet\" data-url=\"https://seekingalpha.com/news/1427821-fda-denies-amarins-anchor-spa-appeal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1427621\" data-ts=\"1385115885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1427621-world-stocks-mixed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World stocks mixed</a></h4><ul>   <li>Global equities are mixed heading into the weekend, with a better-than-expected <a href=\"https://seekingalpha.com/currents/post/1427591\" target=\"_blank\">Ifo survey</a> out of Germany failing to keep the DAX above the treadwater line.</li>    <li>Japan <font color='green'>+0.1%</font>, Hong Kong <font color='green'>+0.5%</font>, China <font color='red'>-0.4%</font>, India <font color='red'>-0.1%</font>.</li>    <li>EU Stoxx 50 <font color='red'>-0.05%</font>, London <font color='red'>-0.1%</font>, Paris <font color='green'>+0.3%</font>, Frankfurt <font color='red'>-0.1%</font>, Milan <font color='red'>-0.3%</font>, Madrid <font color='red'>-0.1%</font>.</li>     <li>U.S. stock futures: Dow <font color='green'>+0.1%</font>. S&amp;P flat. Nasdaq <font color='green'>+0.1%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"1427621\" data-linked=\"World stocks mixed\" data-tweet=\"World stocks mixed https://seekingalpha.com/news/1427621-world-stocks-mixed?source=tweet\" data-url=\"https://seekingalpha.com/news/1427621-world-stocks-mixed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 AM </div></div></li>","count":64,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}